tldrdailynews.com logo
Tag

Hims And Hers Health

All articles tagged with #hims and hers health

On Holding tops estimates as premium strategy pays off; Hims & Hers posts surprise loss, shares slide
business17 days ago

On Holding tops estimates as premium strategy pays off; Hims & Hers posts surprise loss, shares slide

On Holding beat Wall Street with $1.07B revenue and $0.40 adjusted EPS for Q1 2026, and lifted profitability targets to at least 64.5% gross margin and 19.5–20% EBITDA margin for 2026. In contrast, Hims & Hers Health swung to a Q1 net loss of $92.1M (−$0.40 per share) on $608M revenue, missing estimates, as it pivots to branded GLP-1 products and partners with Novo Nordisk; the stock fell about 8% after hours amid the weaker results.

via Yahoo Finance Singapore|
#after-hours-reaction#business#earnings
Peptides as Next Growth Frontier for Hims & Hers as GLP-1 Business Evolves
business1 month ago

Peptides as Next Growth Frontier for Hims & Hers as GLP-1 Business Evolves

Hims & Hers Health is pursuing peptides as a potential growth driver as its high‑margin compounded GLP‑1 business matures. The FDA plans a July 2026 review of peptides for possible inclusion on the 503A bulk list, a step that could enable regulated, physician‑led peptide therapy and unlock new revenue, though progress is not immediate and clinical evidence is limited. The company bought a peptide facility in 2025 and intends to steer users toward branded therapies rather than proprietary compounded GLP‑1 drugs.

via CNBC|
#business#fda#glp-1
Hims & Hers Surges 27% After Announcing Affordable GLP-1 Injections
finance2 years ago

Hims & Hers Surges 27% After Announcing Affordable GLP-1 Injections

Hims & Hers Health, a telehealth company, has surged to nearly $20 per share following a major product announcement involving GLP-1 agonists for weight loss. The company offers these products at significantly lower costs without requiring health insurance, attracting more consumers. With a rapidly growing customer base and diverse healthcare offerings, Hims & Hers is poised for substantial long-term growth, making it a compelling investment at its current price.

via The Motley Fool|
#finance#glp-1-agonists#hims-and-hers-health